Driving your Business in the Ecosystem Era: Why Executives Need the Keys, Not the Blueprint

Driving the IIBE Car as your Architectural Design

1. Executive Briefing

The Tension: Executive teams recognize their legacy business models are buckling under market friction, yet every attempt to build an ecosystem stalls under a mountain of complex blueprints, system schematics, and theoretical frameworks.

The Cause: Most ecosystem advisors attempt to teach the C-suite how to tune the engine transmission instead of handing them a precision-engineered vehicle ready to drive across volatile multi-partner terrain.

The Outcome: The IIBE Operational Engine decouples architectural engineering from daily leadership—providing the pre-built scaffolding, adaptive governance, and dynamic sensing required for executives to focus entirely on driving compounding growth from Point A to Point C.

The Intelligent Integrated Business Ecosystem (IIBE) is an architecture for diagnosing, designing and orchestrating ecosystems of independent partners. It combines human meaning, AI sensing and ecosystem flow, so that purpose, value, governance and data work together as the ecosystem evolves.

It is built for situations where partners are independent and cannot simply be directed. The IIBE reads whether an ecosystem holds together, shows where leverage and dependence sit, and sets out an ordered path to act on what it finds.

Continue reading →

Worried About Operational Execution & Governance for Accountability at the Edge

Governing Multi-Partner Initiatives When No One Is in Charge

1. Executive Briefing

The Tension: Cross-company alliances and ecosystem initiatives routinely stall when critical decisions must be made across organizational boundaries where traditional corporate authority and line-management cease to apply.

The Cause: Enterprise leaders attempt to enforce internal, hierarchy-driven management structures onto external partner networks, triggering governance inertia, friction, and operational paralysis at the network edge.

The Outcome: Implementing five decentralized design principles for Accountability at the Edge establishes clear decision rights, dynamic signal routing, and shared commitment frameworks without requiring central ownership.

Continue reading →

Are You Winning At Ecosystems, Not as a Single Entity

Charting a pathway of collaboration to a successful Ecosystem

The New Competitive Reality: Winning as an Ecosystem, Not a Single Entity

Executive Briefing: For decades, market leadership meant building the strongest isolated company in the room—best product, best sales force, lowest price.

Today, established market leaders are losing deals to competitors with inferior single-entity technology.

The ground has shifted: incumbents are competing as single entities against rivals operating as assembled multi-actor collaboration hubs.

Continue reading →

Have You What It Takes To Build Multi-Actor Scaling Capability

Starting here in any Diagnostic for Building Ecosystems

Executive Briefing: Most business ecosystems hit a growth ceiling because they remain stuck at the problem-recognition level. Enterprise leaders recognize the system is resisting them, yet they attempt to solve boundary friction using traditional partner management tools.

Moving beyond platform activity requires an explicit Ecosystem Architecture built on three structural requirements: an explicit blueprint, a shared ecosystem grammar, and distributed network intelligence.

Continue reading →

Facing Up To The Platform Fallacy: Hitting the Invisible Growth Wall

Recognizing the limitations within one organization

Executive Briefing: Industrial giants—from Siemens and Schneider Electric to Novartis, Roche, and Maersk—continue to pour billions into digital platforms, developer portals, and API marketplaces. Yet, despite massive capital expenditure, compounding network value stalls.

This stagnation occurs because platforms taught leadership the wrong strategic logic. Platforms enforce centralized gatekeeping, ownership of flows, and aggressive value capture. True ecosystems require decentralized alignment, dynamic orchestration, and reciprocal value creation.

Continue reading →

Restructured Blueprint: “Evaluating Actual Business Ecosystems Using the Nine-Dimension Diagnostic”

A structured X-Ray from the IIBE to Evaluate Ecosystem Maturity

Evaluating Ecosystem Maturity: The Nine-Dimension Diagnostic

Executive Briefing: Evaluating whether an organization possesses a true ecosystem operating model—rather than an expanded partner program—requires testing against real-world evidence across 9 core architectural dimensions.

Comparative Analysis: A cross-sector diagnostic test comparing industrial incumbents (Siemens AG, Schneider Electric) against digital ecosystem leaders (Salesforce, Alibaba) reveals a fundamental divide: traditional industrial leaders govern ecosystems via control and channel management, whereas digital platforms generate self-reinforcing growth via data intelligence flows and emergent partner value.

Continue reading →

Evaluating Actual Business Ecosystems Using the Nine Dimension Diagnostic

Applying the Diagnostic

I built the Nine Dimensions comparative diagnostic to evaluate the differences between organisations on their Ecosystem journey to gain both insights and potential gaps that might want to be filled, hopefully with my help.

Recently I undertook a set of focused evaluations on different Healthcare organizations- Novartis, Roche, Bayer, Royal Philips and Siemens Healthineers for understanding their present Ecosystem position.

My next step was to extend this diagnostic approach across into other sectors as well, in wanting to establish a more updated “universal” diagnostic tool. This post takes me into the Industrial sector and the e-commerce one

So,stepping out of the work achieved in the Heathcare sector I have actually re-tested* against a group of Industrial and e-commerce offering marketplaces connecting businesses and buyers worldwide. I chose Siemens AG, Schneider Electric, Salesforce and Alibaba.

*Why re-tested? In much earlier work on Ecosystem validations I used a different nine dimensions, more general-purpose instrument: it was good for establishing “does this company have ecosystem architecture at all,” weak for discriminating between companies that are all somewhere in the ecosystem-emerging middle or their own ecosystem understanding. It helped me learn and relate as I was building my IIBE blueprint

This revised Nine Dimension is a sharper, more comparative instrument because it was built (or refined) under the pressure of actually needing to differentiate real companies against each other, not designed in the abstract.

This was a test to run pulling current evidence on each company’s actual ecosystem/partner model. In this specific diagnostic I had expected a cleaner split between Siemens and Schneider and Salesforce and Alibaba as these two are regarded as more mature in their Ecosystem approaches

Continue reading →

Driving the future of Healthcare through an Ecosystem approach – Here’s a Plan

A structured X-Ray from the IIBE

If You’re a Healthcare Diagnostics Company, Here’s What the IIBE Diagnostic Actually Means for You

You’re in a tough position:

  • You have strong diagnostic technology.
  • You face entrenched incumbents with distribution power.
  • You’re being shut out of established channels.
  • Building your own ecosystem feels expensive and slow.
  • Joining someone else’s ecosystem feels risky or unclear.
  • You’re unsure where the leverage actually is.

This is exactly the kind of situation the *IIBE Diagnostic is built for.

Let me show you how as someone who feels the pressure of entrenched competitors, rising costs, and the uncertainty of whether to build, join, or partner into an ecosystem. I’ll answer in a way that is clear, strategic, and grounded in the IIBE architecture

*IIBE stands for Intelligent Integrated Business Ecosystem – the architectural approach to Ecosystems.

1. The Diagnostic Gives You a Structural X‑Ray of Your Strategic Position

Continue reading →

Novartis Has Built Two Ecosystems. It Hasn’t Connected Them Yet. They Should.

The Converging Forces We Need To Connect Up

Vas Narasimhan (the CEO, Novartis) has named it directly: becoming the number one partner in the technology ecosystem is one of Novartis’s four digital strategic pillars. That is not aspirational language dropped into an investor deck. It is explicit ecosystem intent at CEO level, and it is rare in global pharma.

Novartis has acted on it. Two remarkable architectures now exist inside the company, each sophisticated enough to be a case study on its own.

I took a look at Novatis and its intent though a different approach here, exploring the results from the Intelligent Integrated Business Ecosystem (IIBE) and raising some fairly important Ecosystem building questions on Novartis, based on my analysis as part of the Healthcare research undertaken

So these two remarkable architectures seem to have so much value left on the table. There seems much to do on taking these to a very different level

Continue reading →

Evaluating Bayer and Roche for their future Ecosystem potential

Starting here in any Diagnostic for Building Ecosystems

Within my work on Ecosystems a significant amount of this is through Diagnostics that leads to Discovery.

Over the past month or so I have been focusing on the Healthcare section and through a number of my diagnostic tools assessed GE Healthcare, Siemens Healthineers, Royal Philips, Novartis, Bayer and Roche.

Why Healthcare? If ever the potential for applying Ecosystem thinking and design it would be in Healthcare. Yet there is so much fragmentation, current relationship constraints and design obstacles to. resolve.

I have posted observations on Siemens Healthineers (post here) and Royal Philips recently. Specifically for Royal Philips I did a very extensive Business Case outline over four posts as I took a broader range of my diagnostic tools to apply to them

Here I am focusing on Bayer and Roche, specially through my Nine-dimensional diagnostic. They aim to offer structural truths. They exist whether the organization acknowledges them. The diagnostic does not create them, it makes them visible. The ones outlined here are not part of the total evaluation undertaken, they are an initial snapshot that needs some more detailed input to gain a more definitive result.

The importance within the IIBE is the sequence, handoff, linkage and movements. In this case the nine components shown are here in these results more “stand alone”, indicative of opportunities for organizations to focus and evaluate each component, to recognise the needs to improve or spot the constraints.

The results for Bayer and Roche offered surprising and different results in the stages they are at in Ecosystem design progress

Continue reading →